Angiotensin-(1-7) upregulates (ATP-binding cassette transporter A1) ABCA1 expression through cyclic AMP signaling pathway in RAW 264.7 macrophages

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 7, 2014, Pages 985-991

  Liang, B ^a   Wang, X ^a   Yan, F ^a   Bian, Y F ^a   Liu, M ^a   Bai, R ^a   Yang, H Y ^a   Zhang, N N ^a   Yang, Z M ^a   Xiao, C S ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); ATP binding cassette transporter A1; Cyclic AMP; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; ADENYLATE CYCLASE INHIBITOR; ANGIOTENSIN[1-7]; CHOLESTEROL; CYCLIC AMP; MESSENGER RNA; N (2 PHENYLCYCLOPENTYL)AZACYCLOTRIDECAN 2 IMINE; ABCA1 PROTEIN, MOUSE; ADENYLATE CYCLASE; ANGIOTENSIN I; ANGIOTENSIN I (1-7); IMINE; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENETICS; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; UPREGULATION;

ADENYLATE CYCLASE; ANGIOTENSIN I; ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; CELL LINE; CYCLIC AMP; IMINES; MACROPHAGES; MICE; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84902131861     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. CHOUDHURY R.P., LEE JM, GREAVES DR Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med 2005; 2: 309-315. (Pubitemid 40852635)
2. YUAN Y, LI P, YE J. Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell 2012; 3: 173-181.
3. ESCOLA-GIL J.C., ROTLLAN N, JULVE J., BLANCO-VACA F. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis 2009; 206: 321-327.
4. LEE CH, TAI BC, LIM G.H., CHAN MY, LOW A F, TAN KC, CHIA B.L., TAN HC. Correlation between high density lipoprotein-cholesterol and remodeling index in patients with coronary artery disease: IDEAS (IVUS diagnostic evaluation of atherosclerosis in Singapore)-HDL study. Int J Cardiovasc Imaging 2012; 28: 33-41.
5. ROSENSON RS, BREWER HB, JR., DAVIDSON WS, FAYAD ZA, FUSTER V, GOLDSTEIN J, HELLERSTEIN M, JIANG XC, PHILLIPS MC, RADER DJ, REMALEY AT, ROTHBLAT GH, TALL AR, YVAN-CHARVET L. Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport. Circulation 2012; 125: 1905-1919.
6. FITZGERALD ML, MUJAWAR Z, TAMEHIRO N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010; 211: 361-370.
7. SCHMITZ G, LANGMANN T. Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 2001; 12: 129-140. (Pubitemid 32242920)
8. HAIDAR B, DENIS M, KRIMBOU L., MARCIL M, GENEST J, JR. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 2002; 43: 2087-2094. (Pubitemid 35471076)
9. WITZLACK T, WENZECK T, THIERY J., ORTH M. cAMP-induced expression of ABCA1 is associated with MAP-kinase-pathway activation. Biochem Biophys Res Commun 2007; 363: 89-94. (Pubitemid 47430098)
10. CHEN L, XIAO J, LI Y., MA H. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats. Eur Rev Med Pharmacol Sci 2011; 15: 1-7.
11. LOOT AE, ROKS AJ, HENNING R.H., TIO RA, SUURMEIJER AJ, BOOMSMA F, VAN GILST WH. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002; 105: 1548-1550. (Pubitemid 34297630)
12. TALLANT EA, CLARK MA Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 2003; 42: 574-579. (Pubitemid 37237356)
13. PRASANNARONG M, SANTOS FR, HENRIKSEN EJ ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem Biophys Res Commun 2012; 426: 369-373.
14. WANG L, HU X, ZHANG W., TIAN F. Angiotensin (1-7) ameliorates angiotensin II-induced inflammation by inhibiting LOX-1 expression. Inflamm Res 2013; 62: 219-228.
15. YANG H.Y., BIAN Y F, ZHANG H P, GAO F, XIAO C.S., LIANG B., LI J, ZHANG NN, YANG ZM. Angiotensin-(1-7) treatment ameliorates angiotensin II-induced apoptosis of human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol 2012; 39: 1004-1010.
16. AYAORI M, SAWADA S, YONEMURA A., IWAMOTO N, OGU-RA M, TANAKA N, NAKAYA K., KUSUHARA M, NAKAMURA H, OHSUZU F. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages. Arterioscler Thromb Vasc Biol 2006; 26: 163-168. (Pubitemid 43732244)
17. HU YW, WANG Q, MA X., LI XX, LIU XH, XIAO J, LIAO D F, XIANG J, TANG CK. TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells. J Atheroscler Thromb 2010; 17: 493-502.
18. SCHEIDEGGER KJ, BUTLER S, WITZTUM JL Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-de-pendent pathway. J Biol Chem 1997; 272: 21609-21615. (Pubitemid 27374038)
19. SODERLING SH, BEAVO JA Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 2000; 12: 174-179. (Pubitemid 30142563)
20. SCHMIDT M, DEKKER FJ, MAARSINGH H. Exchange protein directly activated by cAMP (epac): A multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol Rev 2013; 65: 670-709.